- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01270100
Recovery Management Intervention in China
Reducing HIV/AIDS and Drug Abuse Among Heroin Addicts Released From Compulsory Rehabilitation in China
The purpose of the study is to develop and pilot-test a Recovery Management Intervention (RMI) program for heroin addicts released from compulsory rehabilitation in China.
The project has the following specific aims:
Primary aims:
Aim 1. To engage key stakeholders in the local communities involved in supporting the transition of heroin addicts released from compulsory rehabilitation to the community; Aim 2. To identify potential barriers for participating in MMT in China; Aim 3. To develop and deliver educational/training materials on HIV risks, relapse prevention, and MMT; Aim 4. To adapt and develop the Recovery Management Intervention (RMI) program for heroin addicts released from compulsory rehabilitation in China; Aim 5. To conduct a pilot trial and obtain preliminary outcome data associated with RMI, relative to enhanced standard care.
Secondary aim:
Aim 6. To explore predictors of relapse and HIV/AIDS risk behaviors.
It is hypothesized that the intervention will reduce drug use relapse and the negative consequences associated with relapse, including HIV risk behaviors
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Shanghai, China
- Shanghai Mental Health Center
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:The study population will be drawn from all adult patients at participating compulsory rehabilitation facilities who:
- have been incarcerated for at least one year and would have been eligible for MMT at the time of incarceration,
- have at least 1 month remaining before release,
- met the DSM-IV criteria for heroin dependence at the time of incarceration,
- are willing to enroll in methadone maintenance treatment, and
- are Shanghai residents who reside in the areas of Shanghai targeted by the study.
Exclusion Criteria: Individuals diagnosed with severe mental illness will not be eligible to participate.
Study Plan
How is the study designed?
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
EXPERIMENTAL: Recovery management intervention
|
Collaborators and Investigators
Collaborators
Publications and helpful links
Study record dates
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (ESTIMATE)
Study Record Updates
Last Update Posted (ESTIMATE)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- DA025385
- 1R21DA025385-01 (NIH)
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on HIV Infections
-
University of MinnesotaWithdrawnHIV Infections | HIV/AIDS | Hiv | AIDS | Aids/Hiv Problem | AIDS and InfectionsUnited States
-
University of California, San DiegoUniversity of California, Los Angeles; University of Southern California; California... and other collaboratorsCompleted
-
Gérond'ifRecruiting
-
University of California, DavisCompleted
-
University of California, San DiegoNational Center for Complementary and Integrative Health (NCCIH)CompletedHIV PositiveUnited States
-
University of ChicagoUniversity of Athens; National Development and Research Institutes, Inc.Completed
-
HIV Prevention Trials NetworkNational Institute on Drug Abuse (NIDA); National Institute of Allergy and...CompletedHIV PositiveIndonesia, Ukraine, Vietnam
-
University of ZimbabweCompleted
-
Florida International UniversityCompleted
-
Boston Children's HospitalNational Institute on Minority Health and Health Disparities (NIMHD)Completed
Clinical Trials on Recovery management
-
Yale UniversityNational Institute of Mental Health (NIMH); VA Connecticut Healthcare SystemCompletedSchizophrenia | Bipolar Disorder | Dual DiagnosisUnited States
-
Hospices Civils de LyonInstitut National de la Santé Et de la Recherche Médicale, FranceRecruiting
-
New York State Psychiatric InstituteEmory UniversityCompletedDepressive Disorder | Bipolar Disorder | Mental Disorders, Severe | Schizophrenia and Related Disorders
-
University Hospital, AkershusHelse Sor-Ost; RomeriksprosjektetCompletedMental Disorders | Mood Disorders | Schizophrenia | Bipolar Disorder | Affective Disorders, PsychoticNorway
-
Dartmouth-Hitchcock Medical CenterPatient-Centered Outcomes Research InstituteRecruiting
-
Dartmouth-Hitchcock Medical CenterPatient-Centered Outcomes Research InstituteCompletedChronic Disease | Mental IllnessUnited States
-
Karolinska InstitutetDalarna County Council, SwedenActive, not recruitingPsychotic Disorders | Antisocial Personality Disorder | Substance Use Disorders | Forensic Psychology | Forensic NursingSweden
-
The Affiliated Hospital of Qingdao UniversityCompleted
-
Vanderbilt University Medical CenterCompletedSchizophrenia and Related DisordersUnited States
-
The Second Hospital of Shandong UniversityRecruitingLung Cancer | Surgery | ERASChina